More than half (53 percent) of U.S. consumers want to know what’s in their DNA, according to a new survey released today by health technology company Counsyl. Yet only seven percent of respondents say that their doctor has discussed genetic screening with them.
“The survey findings speak to the public’s appetite to know what’s in their DNA – something we’re encouraged to see, since early awareness of risk can make a big difference in health outcomes,” said Ramji Srinivasan, co-founder and CEO at Counsyl. “There is still much to be done, though, in helping patients and physicians understand how advancements have made genetic screening cost-effective and results delivery easy to navigate, so that potentially life-changing information can be within everyone’s reach.”
The nationwide survey, conducted by independent research company ORC International among a representative sample of 1,020 adults, explored knowledge of and attitudes toward genetic testing among adult consumers. The strong interest in genetic screening that is evident from the survey can be attributed to a variety of factors, but may point to an interest among consumers in using genetic screening to be more proactive about their healthcare.